<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="correction" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1393029</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2024.1393029</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Erratum</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Erratum: PDE9 inhibitor PF-04447943 attenuates DSS-induced colitis by suppressing oxidative stress, inflammation, and regulating T-cell polarization</article-title>
<alt-title alt-title-type="left-running-head">Frontiers Production Office</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2024.1393029">10.3389/fphar.2024.1393029</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<collab>Frontiers Production Office</collab>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/20170/overview"/>
</contrib>
</contrib-group>
<aff>
<institution>Frontiers Media SA</institution>, <addr-line>Lausanne</addr-line>, <country>Switzerland</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Approved by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/20178">Frontiers Editorial Office</ext-link>, Frontiers Media SA, Switzerland</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Frontiers Production Office, <email>production.office@frontiersin.org</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>11</day>
<month>03</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1393029</elocation-id>
<history>
<date date-type="received">
<day>28</day>
<month>02</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>02</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Frontiers Production Office.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Frontiers Production Office</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="corrected-article" journal-id="Front. Pharmacol." journal-id-type="nlm-ta" xlink:href="10.3389/fphar.2021.643215" ext-link-type="doi">An Erratum on <article-title>PDE9 inhibitor PF-04447943 attenuates DSS-induced colitis by suppressing oxidative stress, inflammation, and regulating T-cell polarization</article-title> by Rana MN, Lu J, Xue E, Ruan J, Liu Y, Zhang L, Dhar R, Li Y, Hu Z, Zhou J, Ma W and Tang H (2021). Front. Pharmacol. 12:643215. doi: <object-id>10.3389/fphar.2021.643215</object-id>
</related-article>
<kwd-group>
<kwd>ulcerative colitis</kwd>
<kwd>PF-04447943</kwd>
<kwd>inflammasome</kwd>
<kwd>Treg/Th17 cell balance</kwd>
<kwd>PDE9A</kwd>
<kwd>oxidative stress</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Inflammation Pharmacology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>Due to a production error, a footnote (&#x2020;) to the author list was incomplete and was also incorrectly not applied to the author Mohammad Nasiruddin Rana. The correct author list and footnote are as follows:</p>
<p>Mohammad Nasiruddin Rana<sup>1&#x2020;</sup>, Jie Lu<sup>2&#x2020;</sup>, Enfu Xue<sup>1&#x2020;</sup>, Jingjing Ruan<sup>1&#x2020;</sup>, Yuting Liu<sup>1&#x2020;</sup>, Lejun Zhang<sup>1</sup>, Rana Dhar<sup>1</sup>, Yajun Li<sup>1</sup>, Zhengqiang Hu<sup>1</sup>, Jie Zhou<sup>3</sup>, Wangqian Ma<sup>4&#x2a;</sup> and Huifang Tang<sup>1&#x2a;</sup>
</p>
<p>
<sup>&#x2020;</sup> These authors have contributed equally to this work and share first authorship</p>
<p>The publisher apologizes for this mistake. The original version of this article has been updated.</p>
</body>
</article>